| Financial Year |
March 31 2023 |
| Monetary Funds |
116,961,001.63 |
| Held-for-trading Financial Assets |
29,106,000.00 |
| Notes Receivable |
234,530.00 |
| Accounts Receivable |
32,573,818.18 |
| Advances to Suppliers |
1,846,605.14 |
| Other Receivables |
345,077.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
98,787,788.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,000,000.00 |
| Other Current Assets |
7,070.68 |
| Total Current Assets |
310,282,148.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,513,725.02 |
| Investment Properties |
6,473,884.05 |
| Fixed Assetes |
128,095,368.21 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,064,320.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
599,366.73 |
| Deferred Income Tax Assets |
2,739,784.44 |
| Other Non-Current Assets |
45,000.00 |
| Sub-Total of Non-Current Assets |
178,142,854.21 |
| Total Assets |
488,425,002.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,056,255.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,978,129.97 |
| Taxes Payable |
2,588,545.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,113,306.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,221,581.72 |
| Sub-Total of Current Liabilities |
25,759,806.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,375,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,459,037.84 |
| Total Liabilities |
29,218,844.41 |
| Paid-In Capital(Or Share Stock) |
136,190,823.00 |
| Capital Surplus |
49,873,576.70 |
| Surplus Reserve |
52,662,052.10 |
| LESS:Treasury Stock |
30,804,478.89 |
| Undistributed Profits |
256,084,072.71 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
459,206,158.07 |
| Owner's Equity（Stockholder's Equity） |
459,206,158.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
488,425,002.48 |
